MondayDec 14, 2020 3:11 pm

HempFusion Wellness, Inc. Raising the Bar for CBD Products as It Heads for Public Listing on Toronto Stock Exchange

HempFusion is one of 12 companies working on a study to address FDA comments about CBD and human interaction, studying the cannabinoid’s effects on the human liver The company could become publicly traded on the Toronto Stock Exchange as early as the week starting December 14, 2020 By 2025, the global CBD market is estimated to reach $23.6 billion HempFusion plans to extend product offering to include beverages, edibles, and pet products, which has become a growing segment in the CBD industry A leader in the health and wellness cannabidiol industry, HempFusion Wellness is raising the bar for CBD products…

Continue Reading

MondayDec 14, 2020 2:20 pm

Net Element (NASDAQ: NETE) Revenues Improve During COVID Upheaval; Company Prepping for Upcoming Merger

Report notes that NETE is showing surprising business strength despite lockdowns persisting in New York, California Once restrictions are eased, company should rebound sharply Agreement between NETE, Mullen outlines stock-for-stock reverse merger in which Mullen stockholders will receive outstanding stock in post-merger company With its previously announced definitive agreement with Mullen Technologies, a Southern California-based electric vehicle company, still in process, Net Element (NASDAQ: NETE) is valued only on its card-processing business. With 45% of its customers in the restaurant business — a space that has been deeply impacted by COVID-19 — Net Element revenues actually improved sequentially, reported a…

Continue Reading

MondayDec 14, 2020 1:31 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Technology to Change Current Standard of Care for Bladder Cancer Patients

The company’s proprietary technology could change the way surgeons handle cystoscopy procedures by displaying white light and blue light images side-by-side on one screen The technology is primarily promoted as an imaging device for bladder cancer but has the potential to expand to other endoscopic procedures including laparoscopic, colorectal and thoracic Bladder cancer is the sixth most prevalent cancer in the United States, with 600,000 people fearing recurrence The global market for bladder cancer is estimated to grow to an estimated $4.71 billion by 2026 The current standard of care for bladder cancer is minimally invasive surgery (MIS)uses white light…

Continue Reading

MondayDec 14, 2020 12:01 pm

SRAX Inc.’s (NASDAQ: SRAX) Sequire Helps Companies Gather Investor Insights, Harness Big Data to Improve Investor Interactions

Collection and use of big data have become increasingly important to any company seeking to interact with its stakeholders SRAX’s Sequire, an investor intelligence platform, provides its publicly listed corporate client base with insights gleaned from over 1 million strong investor user base Sequire allows companies to accurately gather, harness key investor data points, which can help boost their market value and shareholder base SRAX (NASDAQ: SRAX), a financial technology company focused around unlocking data and insights for publicly traded companies through Sequire, has seen its services gain increased prominence as investors and corporations radically shift the manner in which…

Continue Reading

FridayDec 11, 2020 2:03 pm

Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Is ‘One to Watch’

Loop Insights is aiming to disrupt multiple global markets with its proprietary technologies, including Fobi, SmarTap, Uklipz and the Loop cloud Loop successfully deployed the world’s first complete, end-to-end “venue bubble” solution, protecting over 500 NCAA players and staff at the 2020 Gulf Coast Showcase Loop Insights’ automated venue tracing service provides real-time notifications of potential COVID-19 exposure and can be used for alerting users during natural disasters or amber alerts Loop has established partnerships with a trio of medical testing companies, enabling it to provide a complete end-to-end integrated COVID-19 management platform that includes rapid testing, integrated lab results…

Continue Reading

FridayDec 11, 2020 1:35 pm

Josemaria Resources Inc.’s (TSX: JOSE) (OTC: JOSMF) Argentina Project Could Benefit from Two-Year High Copper Prices

Rising copper prices tied to COVID-19 vaccine breakthroughs Market expert notes that “positive news for the metals is compounding and copper is gaining momentum” JOSE focused on development of its Josemaria Copper-Gold Project In an intriguing take on the COVID-19 global pandemic, copper prices have reached a two-year high because of the connection the base metal has to vaccine breakthroughs (https://ibn.fm/l2Z8y). Those increasing prices bode well for Josemaria Resources (TSX: JOSE) (OTC: JOSMF), a natural resources company that is focused on developing its wholly owned Josemaria Copper-Gold Project in Argentina. “On the Comex market, copper for delivery in December gained…

Continue Reading

FridayDec 11, 2020 1:05 pm

CannAssist International (CNSC) Prepares to Take CBD Product Market by Storm

CannAssist International’s Xceptor Labs is active player within CBD-based product sector Global CBD product market is expected to rise in value from $4.6 billion in 2018 to over $23 billion by 2025 Xceptor Labs differentiating product range through use, development of proprietary CiBiDinol technology CiBiDinol technology covers the oil soluble CBD molecule with a water soluble carrier thereby increasing its bioavailability and enabling easier absorption of product Xceptor Labs has recently launched its Xceptol product line, comprised of topical pain creams, CBD-derived capsules, tinctures and pet drops CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company which has…

Continue Reading

ThursdayDec 10, 2020 1:18 pm

Net Element, Inc. (NASDAQ: NETE) Prepares for Life in the Fast Lane as It Prepares to Shift into Electric Vehicle Space

Net Element plans to radically transform its business model following completion of merger with Mullen Technologies, converting into pure-play EV manufacturer Electric vehicles are set to account for 3% of global vehicle sales in 2020 Governments have increasingly pushed for electric vehicle adoption as key pillar underpinning environmental objectives; the UK just announced ban on sale of fossil-fuel powered cars by 2030 NETE CEO Oleg Firer recently elaborated on challenges of entrepreneurship, role of diplomacy within modern corporate management Net Element (NASDAQ: NETE) presents its stakeholders with a unique business proposition: Within its role as a global financial technology and…

Continue Reading

ThursdayDec 10, 2020 1:00 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Provides Natural Alternative to Banned Chemicals

Agriculture biotech providing natural organic biopesticide, alternative solution to banned synthetic chemicals. Company focused on high-value crops in North, South American market with view to expanding. MBRO delivers unique product larger producers failed to deliver, offers robust growth potential MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) COO Colin Bletsky was featured in a recent SmallCap-Investor interview (https://ibn.fm/Ax1Bd). During the interview, Bletsky discussed the company and its unique value proposition and ambitious plans for the future. MustGrow is an innovative agriculture biotech company providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops such as fruit and…

Continue Reading

ThursdayDec 10, 2020 12:43 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Brain Cancer Drug IND Filing Accepted for Review by FDA

CNS Pharmaceuticals featured in audio broadcast distributed to thousands of syndication points. Berubicin IND accepted for review by FDA Phase 1 trial showed 44% of patients experiencing clinical benefit of stable disease or better Adult Phase 2 trials to commence in Q1 2021 The IND filing for brain cancer drug Berubicin has been accepted for review by the U.S. Food and Drug Administration (“FDA”), reports CNS Pharmaceuticals (NASDAQ: CNSP), the company now responsible for the drugs’ development. That news was featured in a recent syndicated NetworkNewsAudio (“NNA”) broadcast, which covered CNS Pharmaceuticals’ recent submission of an Investigational New Drug (“IND”)…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered